ANDOVER,
Mass., Feb. 28, 2024 /PRNewswire/ -- TransMedics
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology
company that is transforming organ transplant therapy for patients
with end-stage lung, heart, and liver failure, today announced the
company will be participating in two upcoming investor conferences.
TransMedics management is scheduled to participate in a
fireside chat at the TD Cowen 44th Annual Health Care
Conference in Boston on
Monday, March 4, 2024, at
9:50 a.m. EST and to present
virtually at the Oppenheimer 34th Annual Healthcare
MedTech & Services Conference on Tuesday, March 12, 2024, at 12:40 p.m. EST.
Event: TD Cowen 44th Annual Health Care
Conference
Date: Monday, March 4,
2024
Time: 9:50 a.m. EST
Event: Oppenheimer 34th Annual Healthcare MedTech
& Services Conference
Date: Tuesday, March 12, 2024
Time: 12:40 p.m. EST
A live and archived webcast of the presentations will be
available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm perfusion and
assessment of donor organs for transplantation. Headquartered in
Andover, Massachusetts, the
company was founded to address the unmet need for more and better
organs for transplantation and has developed technologies to
preserve organ quality, assess organ viability prior to transplant,
and potentially increase the utilization of donor organs for the
treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian
Johnston
332-895-3222
Investors@transmedics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-upcoming-march-investor-conferences-302074682.html
SOURCE TransMedics Group, Inc.